Hybrid phage displaying SLAQVKYTSASSI induces protection against Candida albicans challenge in BALB/c mice

Human Vaccines and Immunotherapeutics

Volumn 10, Issue 4, 2014, Pages 1057-1063

  Wang, Yicun ^a   Su, Quanping ^a   Dong, Shuai ^a   Shi, Hongxi ^a   Gao, Xiang ^a   Wang, Li ^a  

^a NORTHEAST NORMAL UNIVERSITY   (China)

Author keywords

C. albicans; Cytokines; Phage; Sap2

Indexed keywords

CYTOKINE; EPITOPE; RECOMBINANT PROTEIN; RECOMBINANT VACCINE; VIRUS VACCINE; ASPARTIC PROTEINASE; DRUG CARRIER; FUNGAL PROTEIN; FUNGUS ANTIBODY; FUNGUS ANTIGEN; FUNGUS VACCINE; SAP2 PROTEIN, CANDIDA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY DETECTION; ANTIBODY RESPONSE; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE GENE; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; DRUG EFFECT; FEMALE; FUNGAL COLONIZATION; FUNGAL GENE; FUNGUS IDENTIFICATION; HUMORAL IMMUNITY; IMMUNE RESPONSE; INFECTION PREVENTION; MOUSE; NONHUMAN; PHAGE DISPLAY; SPLEEN CELL; TH1 CELL; TH17 CELL; ANIMAL; BACTERIOPHAGE; BAGG ALBINO MOUSE; BLOOD; DISEASE MODEL; GENE VECTOR; GENETICS; IMMUNOLOGY; SECRETION (PROCESS); SURVIVAL ANALYSIS; T LYMPHOCYTE;

ANIMALS; ANTIBODIES, FUNGAL; ANTIGENS, FUNGAL; ASPARTIC ACID ENDOPEPTIDASES; BACTERIOPHAGES; CANDIDA ALBICANS; CANDIDIASIS; CELL PROLIFERATION; CYTOKINES; DISEASE MODELS, ANIMAL; DRUG CARRIERS; FEMALE; FUNGAL PROTEINS; FUNGAL VACCINES; GENETIC VECTORS; MICE, INBRED BALB C; SURVIVAL ANALYSIS; T-LYMPHOCYTES; VACCINES, SYNTHETIC;

EID: 84899807072     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.27714     Document Type: Article

References (41)

1. Vonk AG, Netea MG, van der Meer JWM, Kullberg BJ. Host defence against disseminated Candida albicans infection and implications for antifungal immunotherapy. Expert Opin Biol Ther 2006; 6:891-903; PMID:16918256; http://dx.doi.org/10.1517/14712598.6.9.891
2. Kullberg BJ, Oude Lashof AM. Epidemiology of opportunistic invasive mycoses. Eur J Med Res 2002; 7:183-91; PMID:12069910
3. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004; 39:309-17; PMID:15306996; http://dx.doi.org/10.1086/421946
4. Cassone A, Casadevall A. Recent progress in vaccines against fungal diseases. Curr Opin Microbiol 2012; 15:427-33; PMID:22564747; http://dx.doi.org/10.1016/j.mib.2012.04.004
5. Edwards JE Jr. Fungal cell wall vaccines: an update. J Med Microbiol 2012; 61:895-903; PMID:22267544; http://dx.doi.org/10.1099/jmm.0.041665-0
6. Khader SA, Gaffen SL, Kolls JK. Th17 cells at the crossroads of innate and adaptive immunity against infectious diseases at the mucosa. Mucosal Immunol 2009; 2:403-11; PMID:19587639; http://dx.doi.org/10.1038/mi.2009.100
7. Fidel PL Jr., Ginsburg KA, Cutright JL, Wolf NA, Leaman D, Dunlap K, Sobel JD. Vaginal-associated immunity in women with recurrent vulvovaginal candidiasis: evidence for vaginal Th1-type responses following intravaginal challenge with Candida antigen. J Infect Dis 1997; 176:728-39; PMID:9291322; http://dx.doi.org/10.1086/514097
8. La Sala A, Urbani F, Torosantucci A, Cassone A, Ausiello CM. Mannoproteins from Candida albicans elicit a Th-type-1 cytokine profile in human Candida specific long-term T cell cultures. J Biol Regul Homeost Agents 1996; 10:8-12; PMID:9049775
9. Cutler JE, Deepe GS Jr., Klein BS. Advances in combating fungal diseases: vaccines on the threshold. Nat Rev Microbiol 2007; 5:13-28; PMID:17160002; http://dx.doi.org/10.1038/nrmicro1537
10. Casadevall A, Pirofski LA. Exploiting the redundancy in the immune system: vaccines can mediate protection by eliciting 'unnatural' immunity. J Exp Med 2003; 197:1401-4; PMID:12782708; http://dx.doi.org/10.1084/jem.20030637
11. Romani L, Mencacci A, Grohmann U, Mocci S, Mosci P, Puccetti P, Bistoni F. Neutralizing antibody to interleukin 4 induces systemic protection and T helper type 1-associated immunity in murine candidiasis. J Exp Med 1992; 176:19-25; PMID:1535368; http://dx.doi.org/10.1084/jem.176.1.19
12. Romani L, Mencacci A, Tonnetti L, Spaccapelo R, Cenci E, Puccetti P, Wolf SF, Bistoni F. IL-12 is both required and prognostic in vivo for T helper type 1 differentiation in murine candidiasis. J Immunol 1994; 153:5167-75; PMID:7963574
13. Taylor BN, Saavedra M, Fidel PL Jr. Local Th1/Th2 cytokine production during experimental vaginal candidiasis: potential importance of transforming growth factor-β. Med Mycol 2000; 38:419-31; PMID:11204879
14. Huang W, Na L, Fidel PL, Schwarzenberger P. Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J Infect Dis 2004; 190:624-31; PMID:15243941; http://dx.doi.org/10.1086/422329
15. Conti HR, Shen F, Nayyar N, Stocum E, Sun JN, Lindemann MJ, Ho AW, Hai JH, Yu JJ, Jung JW, et al. Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J Exp Med 2009; 206:299-311; PMID:19204111; http://dx.doi.org/10.1084/jem.20081463
16. Pirofski LA, Casadevall A. Rethinking T cell immunity in oropharyngeal candidiasis. J Exp Med 2009; 206:269-73; PMID:19204107; http://dx.doi.org/10. 1084/jem.20090093
17. Colina A-R, Aumont F, Deslauriers N, Belhumeur P, de Repentigny L. Evidence for degradation of gastrointestinal mucin by Candida albicans secretory aspartyl proteinase. Infect Immun 1996; 64:4514-9; PMID:8890200
18. Goldman RC, Frost DJ, Capobianco JO, Kadam S, Rasmussen RR, Abad-Zapatero C. Antifungal drug targets: Candida secreted aspartyl protease and fungal wall beta-glucan synthesis. Infect Agents Dis 1995; 4:228-47; PMID:8665087
19. Rüchel R. Cleavage of immunoglobulins by pathogenic yeasts of the genus Candida. Microbiol Sci 1986; 3:316-9; PMID:3153567
20. de Repentigny L, Aumont F, Bernard K, Belhumeur P. Characterization of binding of Candida albicans to small intestinal mucin and its role in adherence to mucosal epithelial cells. Infect Immun 2000; 68:3172-9; PMID:10816460; http://dx.doi.org/10.1128/IAI.68.6.3172-3179.2000
21. Soll DR. High-frequency switching in Candida albicans. Clin Microbiol Rev 1992; 5:183-203; PMID:1576587
22. Schweizer A, Rupp S, Taylor BN, Röllinghoff M, Schröppel K. The TEA/ATTS transcription factor CaTec1p regulates hyphal development and virulence in Candida albicans. Mol Microbiol 2000; 38:435-45; PMID:11069668; http://dx.doi.org/10.1046/j.1365-2958.2000.02132.x
23. Vilanova M, Teixeira L, Caramalho I, Torrado E, Marques A, Madureira P, Ribeiro A, Ferreira P, Gama M, Demengeot J. Protection against systemic candidiasis in mice immunized with secreted aspartic proteinase 2. Immunology 2004; 111:334-42; PMID:15009435; http://dx.doi.org/10.1111/j.1365-2567.2004. 01819.x
24. De Bernardis F, Amacker M, Arancia S, Sandini S, Gremion C, Zurbriggen R, Moser C, Cassone A. A virosomal vaccine against candidal vaginitis: immunogenicity, efficacy and safety profile in animal models. Vaccine 2012; 30:4490-8; PMID:22561143; http://dx.doi.org/10.1016/j.vaccine.2012.04.069
25. Yang Q, Su QP, Wang GY, Wen DZ, Zhang YH, Bao HZ, Wang L. Production of hybrid phage displaying secreted aspartyl proteinase epitope of Candida albicans and its application for the diagnosis of disseminated candidiasis. Mycoses 2007; 50:165-71; PMID:17472610; http://dx.doi.org/10.1111/j.1439-0507.2006. 01349.x
26. Romani L, Howard DH. Mechanisms of resistance to fungal infections. Curr Opin Immunol 1995; 7:517-23; PMID:7495516; http://dx.doi.org/10.1016/0952- 7915(95)80097-2
27. Baker DG. Natural pathogens of laboratory mice, rats, and rabbits and their effects on research. Clin Microbiol Rev 1998; 11:231-66; PMID:9564563
28. Puccetti P, Romani L, Bistoni F. A TH1-TH2-like switch in candidiasis: new perspectives for therapy. Trends Microbiol 1995; 3:237-40; PMID:7648032; http://dx.doi.org/10.1016/S0966-842X(00)88931-3
29. Pietrella D, Rachini A, Pines M, Pandey N, Mosci P, Bistoni F, d'Enfert C, Vecchiarelli A. Th17 cells and IL-17 in protective immunity to vaginal candidiasis. PLoS One 2011; 6:e22770; PMID:21818387; http://dx.doi.org/10.1371/ journal.pone.0022770
30. Ouyang W, Kolls JK, Zheng Y. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 2008; 28:454-67; PMID:18400188; http://dx.doi.org/10.1016/j.immuni.2008.03.004
31. Schaller M, Korting HC, Schäfer W, Bastert J, Chen W, Hube B. Secreted aspartic proteinase (Sap) activity contributes to tissue damage in a model of human oral candidosis. Mol Microbiol 1999; 34:169-80; PMID:10540295; http://dx.doi.org/10.1046/j.1365-2958.1999.01590.x
32. Schaller M, Korting HC, Borelli C, Hamm G, Hube B. Candida albicans-secreted aspartic proteinases modify the epithelial cytokine response in an in vitro model of vaginal candidiasis. Infect Immun 2005; 73:2758-65; PMID:15845479; http://dx.doi.org/10.1128/IAI.73.5.2758-2765.2005
33. Heuer H, Binh CT, Jechalke S, Kopmann C, Zimmerling U, Krögerrecklenfort E, Ledger T, González B, Top E, Smalla K. IncP-1ε Plasmids are Important Vectors of Antibiotic Resistance Genes in Agricultural Systems: Diversification Driven by Class 1 Integron Gene Cassettes. Front Microbiol 2012; 3:2; PMID:22279444; http://dx.doi.org/10.3389/fmicb.2012. 00002
34. Tongchusak S, Brusic V, Chaiyaroj SC. Promiscuous T cell epitope prediction of Candida albicans secretory aspartyl protienase family of proteins. Infect Genet Evol 2008; 8:467-73; PMID:17974505; http://dx.doi.org/10.1016/j. meegid.2007.09.006
35. Quanping S, Yanyan H, Yicun W, Zhigang J, Yuling G, Li W. The use of hybrid phage displaying antigen epitope and recombinant protein in the diagnosis of systemic Candida albicans infection in rabbits and cancer patients. Diagn Microbiol Infect Dis 2010; 68:382-9; PMID:20884151; http://dx.doi.org/10.1016/j. diagmicrobio.2010.07.009
36. Su QP, Wen DZ, Yang Q, Zhang YH, Liu C, Wang L. Comparison of phage pVIII and KLH as vector in inducing the production of cytokines in C57BL/6J mice. Vaccine 2007; 25:970-5; PMID:17055124; http://dx.doi.org/10.1016/j.vaccine.2006. 08.045
37. Yang Q, Wang L, Lu DN, Gao RJ, Song JN, Hua PY, Yuan DW. Prophylactic vaccination with phage-displayed epitope of C. albicans elicits protective immune responses against systemic candidiasis in C57BL/6 mice. Vaccine 2005; 23:4088-96; PMID:15963364; http://dx.doi.org/10.1016/j.vaccine.2004.07.005
38. Prisco A, De Berardinis P. Filamentous bacteriophage fd as an antigen delivery system in vaccination. Int J Mol Sci 2012; 13:5179-94; PMID:22606037; http://dx.doi.org/10.3390/ijms13045179
39. Liu F, Ng TB, Fung MC. Pineal indoles stimulate the gene expression of immunomodulating cytokines. J Neural Transm 2001; 108:397-405; PMID:11475007; http://dx.doi.org/10.1007/s007020170061
40. Wang Y, Li SP, Moser SA, Bost KL, Domer JE. Cytokine involvement in immunomodulatory activity affected by Candida albicans mannan. Infect Immun 1998; 66:1384-91; PMID:9529057
41. Wang Y, Feng D, Liu G, Luo Q, Xu Y, Lin S, Fei J, Xu L. γ-aminobutyric acid transporter 1 negatively regulates T cell-mediated immune responses and ameliorates autoimmune inflammation in the CNS. J Immunol 2008; 181:8226-36; PMID:19050239